Response to Comments on "Aberrant type 1 immunity drives susceptibility to mucosal fungal infections".

Humans Immunity, Mucosal Mucous Membrane Mycoses Animals Mice

Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
17 Sep 2021
Historique:
entrez: 16 9 2021
pubmed: 17 9 2021
medline: 22 9 2021
Statut: ppublish

Résumé

Puel and Casanova and Kisand

Identifiants

DOI: 10.1126/science.abi8835 PMID: 34529475 PMC: PMC10120387
pubmed: 34529475
doi: 10.1126/science.abi8835
pmc: PMC10120387
mid: NIHMS1888956
doi:

Types de publication

Journal Article Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

eabi8835

Subventions

Organisme : NIDCR NIH HHS
ID : R01 DE026600
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI124566
Pays : United States
Organisme : NIAID NIH HHS
ID : K99 AI141622
Pays : United States
Organisme : NIDCR NIH HHS
ID : R00 DE026856
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA AI001175
Pays : United States

Commentaires et corrections

Type : CommentOn
Type : CommentOn

Références

Eur J Immunol. 2011 Jan;41(1):235-45
pubmed: 21182094
Br J Dermatol. 2017 Jul;177(1):47-62
pubmed: 27580411
Cell Host Microbe. 2016 Nov 9;20(5):606-617
pubmed: 27923704
Science. 2021 Sep 17;373(6561):eabi6235
pubmed: 34529474
Blood. 2016 Jun 23;127(25):3154-64
pubmed: 27114460
J Allergy Clin Immunol. 2019 Sep;144(3):750-763
pubmed: 31129129
Science. 2021 Jan 15;371(6526):
pubmed: 33446526
J Leukoc Biol. 2016 Jun;99(6):1153-64
pubmed: 26729813
J Clin Endocrinol Metab. 2017 Sep 1;102(9):3546-3556
pubmed: 28911151
Science. 2011 Apr 1;332(6025):65-8
pubmed: 21350122
Science. 2021 Sep 17;373(6561):eabi5459
pubmed: 34529464
J Immunol. 2008 Aug 15;181(4):2799-805
pubmed: 18684971
J Clin Immunol. 2020 Aug;40(6):807-819
pubmed: 32572726
Annu Rev Immunol. 2009;27:287-312
pubmed: 19302042
J Clin Invest. 2018 Aug 1;128(8):3595-3604
pubmed: 30035749
J Immunol. 2004 Sep 1;173(5):3482-91
pubmed: 15322213
JCI Insight. 2016 Aug 18;1(13):
pubmed: 27588307
J Exp Med. 2010 Feb 15;207(2):291-7
pubmed: 20123958
Front Immunol. 2020 May 08;11:838
pubmed: 32477345
Autoimmunity. 2017 Jun;50(4):211-222
pubmed: 28686485
N Engl J Med. 2009 Nov 19;361(21):2033-45
pubmed: 19890111
Open Forum Infect Dis. 2019 Nov 28;6(12):ofz484
pubmed: 31807607
J Exp Med. 2010 Feb 15;207(2):299-308
pubmed: 20123959

Auteurs

Timothy J Break (TJ)

Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD, USA.

Vasileios Oikonomou (V)

Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD, USA.

Nicolas Dutzan (N)

Oral Immunity and Inflammation Section, National Institute of Dental and Craniofacial Research (NIDCR), Bethesda, MD, USA.

Jigar V Desai (JV)

Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD, USA.

Marc Swidergall (M)

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA.
David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Tilo Freiwald (T)

Immunoregulation Section, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, MD, USA.

Daniel Chauss (D)

Immunoregulation Section, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, MD, USA.

Oliver J Harrison (OJ)

Metaorganism Immunity Section, Laboratory of Immune System Biology, NIAID, Bethesda, MD, USA.

Julie Alejo (J)

Laboratory of Pathology, Center for Cancer Research, National Cancer Institute (NCI), Bethesda, MD, USA.

Drake W Williams (DW)

Oral Immunity and Inflammation Section, National Institute of Dental and Craniofacial Research (NIDCR), Bethesda, MD, USA.

Stefania Pittaluga (S)

Laboratory of Pathology, Center for Cancer Research, National Cancer Institute (NCI), Bethesda, MD, USA.

Chyi-Chia R Lee (CR)

Laboratory of Pathology, Center for Cancer Research, National Cancer Institute (NCI), Bethesda, MD, USA.

Nicolas Bouladoux (N)

Metaorganism Immunity Section, Laboratory of Immune System Biology, NIAID, Bethesda, MD, USA.

Muthulekha Swamydas (M)

Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD, USA.

Kevin W Hoffman (KW)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Teresa Greenwell-Wild (T)

Oral Immunity and Inflammation Section, National Institute of Dental and Craniofacial Research (NIDCR), Bethesda, MD, USA.

Vincent M Bruno (VM)

Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.

Lindsey B Rosen (LB)

Immunopathogenesis Section, LCIM, NIAID, Bethesda, MD, USA.

Wint Lwin (W)

Diabetes Center, University of California, San Francisco, CA, USA.

Andy Renteria (A)

Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD, USA.

Sergio M Pontejo (SM)

Molecular Signaling Section, Laboratory of Molecular Immunology, NIAID, Bethesda, MD, USA.

John P Shannon (JP)

Viral Immunity and Pathogenesis Unit, LCIM, NIAID, Bethesda, MD, USA.

Ian A Myles (IA)

Epithelial Therapeutics Unit, LCIM, NIAID, Bethesda, MD, USA.

Peter Olbrich (P)

Immunopathogenesis Section, LCIM, NIAID, Bethesda, MD, USA.

Elise M N Ferré (EMN)

Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD, USA.

Monica Schmitt (M)

Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD, USA.

Daniel Martin (D)

Genomics and Computational Biology Core, NIDCR, Bethesda, MD, USA.

Daniel L Barber (DL)

T Lymphocyte Biology Section, Laboratory of Parasitic Diseases, NIAID, Bethesda, MD, USA.

Norma V Solis (NV)

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA.

Luigi D Notarangelo (LD)

Immune Deficiency Genetics Section, LCIM, NIAID, Bethesda, MD, USA.

David V Serreze (DV)

The Jackson Laboratory, Bar Harbor, ME, USA.

Mitsuru Matsumoto (M)

Division of Molecular Immunology, Institute for Enzyme Research, Tokushima University, Tokushima, Japan.

Heather D Hickman (HD)

Epithelial Therapeutics Unit, LCIM, NIAID, Bethesda, MD, USA.

Philip M Murphy (PM)

Molecular Signaling Section, Laboratory of Molecular Immunology, NIAID, Bethesda, MD, USA.

Mark S Anderson (MS)

Diabetes Center, University of California, San Francisco, CA, USA.

Jean K Lim (JK)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Steven M Holland (SM)

Immunopathogenesis Section, LCIM, NIAID, Bethesda, MD, USA.

Scott G Filler (SG)

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA.
David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Behdad Afzali (B)

Immunoregulation Section, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, MD, USA.

Yasmine Belkaid (Y)

Metaorganism Immunity Section, Laboratory of Immune System Biology, NIAID, Bethesda, MD, USA.

Niki M Moutsopoulos (NM)

Oral Immunity and Inflammation Section, National Institute of Dental and Craniofacial Research (NIDCR), Bethesda, MD, USA.

Michail S Lionakis (MS)

Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Response to Comments on "Aberrant type 1...
questionsmedicales.fr › Phénomènes du système immunitaire › Immunité › Immunité muqueuse › Response to Comments on "Aberrant type 1...
questionsmedicales.fr › Tissus › Membranes › Muqueuse › Response to Comments on "Aberrant type 1...
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Mycoses › Response to Comments on "Aberrant type 1...
questionsmedicales.fr › Eucaryotes › Animaux › Response to Comments on "Aberrant type 1...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Response to Comments on "Aberrant type 1...